購物車
幫助
021-54845833/15800441009
|
Background: |
DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK2 may modulate the cellular proliferation induced by IL-4, as well as IL-2 and IL-3. May be involved in modulating Bcr-Abl signaling. Attenuates EGF-stimulated MAP kinase activation |
|
Applications: |
WB, IHC, IF |
|
Name of antibody: |
DOK2 (Phospho-Tyr299) |
|
Immunogen: |
Synthetic peptide of human DOK2 (Phospho-Tyr299) |
|
Full name: |
docking protein 2, 56kDa (Phospho-Tyr299) |
|
Synonyms： |
p56DOK; p56dok-2 |
|
SwissProt: |
O60496 |
|
IHC positive control: |
Human breast carcinoma |
|
IHC Recommend dilution: |
50-100 |
|
WB Predicted band size: |
56 kDa |
|
WB Positive control: |
Jurkat cells treated with insulin |
|
WB Recommended dilution: |
500-1000 |
|
IF Positive control: |
Hela cells |
|
IF Recommended dilution |
100-200 |
